Skip to main content

Advertisement

Log in

Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

To determine whether radiotherapy is effective for reducing morphine dose in patients with bone metastasis from lung cancer, a retrospective study was undertaken of 58 patients who had undergone palliative radiotherapy. Mean dose of radiotherapy was 20.26 (range 8–60)  Gy. Daily morphine dose after start of radiotherapy was significantly greater than before radiotherapy, and dose of morphine did not significantly decrease. Radiotherapy appears ineffective for reducing morphine dose in patients with bone metastasis from lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Allard P, Lamontagne C, Bernard P, et al (1999) How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage 17:256–265

    Article  CAS  PubMed  Google Scholar 

  2. Falkmer U, Jarhult J, Wersall P, et al (2003) A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 42:620–633

    Article  PubMed  Google Scholar 

  3. Jeremic B, Shibomoto Y, Acimovic L, et al (1998) A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiation Oncology Biol Phys 42:161–167

    Article  CAS  Google Scholar 

  4. Nielsen OS, Bentzen SM, Sandberg E, et al (1998) Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47:233–240

    Article  CAS  PubMed  Google Scholar 

  5. Ratanatharathorn V, Powers WE, Moss WT, et al (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiation Oncology Biol Phys 44:1–18

    Article  CAS  Google Scholar 

  6. Shakespeare TP, Lu JJ, Back MF, et al (2003) Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol 21:2156–2162

    Article  PubMed  Google Scholar 

  7. Sze WM, Shelley MD, Held I, et al (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15: 345–352

    Google Scholar 

  8. World Health Organization (1996) Cancer pain relief, 2nd edn. World Health Organization, Geneva [Suppl 2]

  9. Wu JSY, Wong R, Johnston M, et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiation Oncology Biol Phys 55:594–605

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiromichi Ishiyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishiyama, H., Shibata, A., Niino, K. et al. Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer. Support Care Cancer 12, 743–745 (2004). https://doi.org/10.1007/s00520-004-0625-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-004-0625-2

Keywords

Navigation